Skip to main content
MACROGENICS INC logo

MACROGENICS INC — Investor Relations & Filings

Ticker · MGNX ISIN · US5560991094 LEI · 5493001KJQUA83L8MH79 US Manufacturing
Open in API
Filings indexed 894 across all filing types
Latest filing 2018-01-25 Major Shareholding Noti…
Country US United States of America
Listing US MGNX

About MACROGENICS INC

https://www.macrogenics.com/

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2018
Major Shareholding Notification
2018-01-25 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 23, 2018. It announces the completion of an interim futility analysis of a Phase 3 clinical trial and the FDA granting Fast Track designation for a drug. The document includes a press release as an exhibit and does not contain detailed financial statements or comprehensive financial analysis. It is a regulatory announcement about clinical trial progress and FDA designation, not a full financial report or earnings release. The document length is 4075 characters, which is relatively short and consistent with a regulatory filing or announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into other specific categories like earnings release or annual report.
2018-01-24 English
FORM 4
Director's Dealing
2018-01-18 English
FORM 4
Director's Dealing
2018-01-18 English
FORM 4
Director's Dealing
2018-01-18 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-01-10 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.